Michelle Lanno

[The PERT Consortium® @PERTConsortium]

What a wonderful PRISM CME Dinner in NYC, supported by @penumbrainc Thank you!

[The PERT Consortium® @PERTConsortium]

Exciting news — Registration is now open for PERT Consortium's 12th Annual Pulmonary Embolism Scientific Symposium 2026 Annual Meeting

Thursday, October 1 – Saturday, October 3, 2026
Join us at the Marriott Copley Plaza in Boston, Massachusetts — we can't wait to see you there!

Register by May 1 to secure the Early Bird Special pricing. 🐦 https://t.co/UM2sMEOTZN

[Endovascular Today @EVToday]

Leaders from The @PERTConsortium, Michelle Lanno (@LannoMichelle), Mahir Elder (@DrMahirElder), Seth Sokol, & Kenneth Rosenfield (@krosenfieldMD), share details on the PRISM Program that aims to increase the PERT concept to improve patient care further. https://t.co/Dm08NIg5JR

[Endovascular Today @EVToday]

AHA/ACC Issue First Acute PE Guidelines With New Clinical Classification System | @American_Heart @ACCinTouch
https://t.co/xPNq2wgYcc

[Michelle Lanno @LannoMichelle]

The Pert Consortium’s 1st International COE. Very impressive program leading the way for PE care.

[The PERT Consortium® @PERTConsortium]

We are proud to announce our first international PE Center of Excellence, King Fahad Medical City in Saudi Arabia!
This prestigious designation recognizes KFMC’s outstanding commitment to evidence-based care, multidisciplinary collaboration, and advancing patient outcomes in pulmonary embolism.
We are especially honored to mark an exciting milestone as PERT’s global impact continues to grow.Congratulations to the @KFMC_RIYADH and @Cluster2_Riyadh on this remarkable achievement!#PEawareness #PulmonaryEmbolism

[The PERT Consortium® @PERTConsortium]

We are proud to announce our first international PE Center of Excellence, King Fahad Medical City in Saudi Arabia!
This prestigious designation recognizes KFMC’s outstanding commitment to evidence-based care, multidisciplinary collaboration, and advancing patient outcomes in pulmonary embolism.
We are especially honored to mark an exciting milestone as PERT’s global impact continues to grow.Congratulations to the @KFMC_RIYADH and @Cluster2_Riyadh on this remarkable achievement!#PEawareness #PulmonaryEmbolism

[The PERT Consortium® @PERTConsortium]

**FINAL CALL FOR PROPOSALS**
The PERT Consortium® is calling all researchers, authors, and investigators to submit their pulmonary embolism research proposals. Accepted proposals will be pursued by the PERT Research Committee, in collaboration with the submitting researcher. Proposals may seek to leverage the real-world-evidence housed in The PERC™ Database.

The deadline for submission is December 5, 2025.
Submitting researchers will be advised on the status of their proposal by December 20, 2025. Please reach out to Carla Kohoyda should you have any questions, or require assistance.

Research proposals may be submitted here: https://t.co/6eOnPj3DVV

[The PERT Consortium® @PERTConsortium]

Breaking news! @RosovskyRachel announced the PE- Storm Trial first and secondary results just published.

[The PERT Consortium® @PERTConsortium]

#VIVA25 #PERT Late-Breaking Deep Dive Session with top PE experts and thought leaders driving innovation in PE care! @RosovskyRachel @EricSecemskyMD @krosenfieldMD @JonnyMoriarty

[The PERT Consortium® @PERTConsortium]

Another incredible moment for PE-Storm at #VIVA25! Honored to have partnered with @PenumbraInc on this groundbreaking trial—paving the way for new standards in pulmonary embolism treatment and outcomes. Congratulations @RosovskyRachel @roblookstein

[Robert A Lookstein MD, MHCDL @roblookstein]

#STORM-PE
CAVT+ AC > AC alone:
1. greater reduction in RV strain
2. Greater improvement in pulm perfusion
3. Faster stabilization of vital signs
4. Faster return to baseline functional status
5. Improved walking distance

Time to offer this tx for all Intermediate-High Risk pts?

[Rachel Rosovsky @RosovskyRachel]

Thank you Circ for simultaneous publication:https://t.co/98p5nhruMX

[Robert A Lookstein MD, MHCDL @roblookstein]

Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial | Circulation https://t.co/8eq5gYvkwO

[Rachel Rosovsky @RosovskyRachel]

Thrilled on behalf of all the STORM-PE investigators and patients to share these groundbreaking results. Thank you Circ for simultaneous publication: https://t.co/98p5nhruMX

[Rachel Rosovsky @RosovskyRachel]

Thank you @Pertconsortium for partnering with Penumbra on this trial.

[The PERT Consortium® @PERTConsortium]

Love seeing our #PERT leadership on the #VIVA25 podium! 👏 Dr. Sayfo, Vice Chair of our #PERT Education Committee

[Penumbra Vascular @PenVascular]

US HCPs: Interested in the future of PE care? Join Drs. James Benenati, Suhail Dohad, Patrick Muck, Parag Patel, and Rachel Rosovsky on November 12th as they share evolving data & innovative approaches for PE management with #CAVT.

Register here: https://t.co/ePs0XBVgIu

[Rachel Rosovsky @RosovskyRachel]

Thank you VIVA and honored to present our late breaking abstract, STORM-PE 90 days results showing earlier physiological recovery and improvement in 90 day functional status with MT + AC vs AC alone in intermediate high risk PE pts. Thank you Circ for simultaneous publication. #VIVA2025 @PERTConsortium

[The PERT Consortium® @PERTConsortium]

#PERTpride in action! Matt from @evttoday is sporting his #PERT 🧢

Every time you wear our #PERTswag, you help share our mission and raise PE awareness.

Curious what #PERT is all about? Visit Booth T3 at #VIVA25 to find out & grab some swag to join the movement.